Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Patients with COVID-19

Source: World Health Organization (WHO). Published: 4/19/2020. This review assesses the effects of prior and current use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with acute viral respiratory infections, such as COVID-19, on acute severe adverse events (including mortality, acute respiratory distress syndrome, acute organ failure, and opportunistic infections), on acute health care utilization (including hospitalization, intensive care unit admission, supplemental oxygen therapy, and mechanical ventilation), as well as on quality of life and long-term survival. (Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news